WPA
HUMA icon

Wealth Preservation Advisors’s Humacyte HUMA Stock Holding History

Wealth Preservation Advisors’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-374
Closed -$227 – 456
2026
Q1 		$227 Buy
+374
New +$389 ﹤0.01% 867

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wealth Preservation Advisors's HUMA Position: Q2 2026 in Review

Wealth Preservation Advisors sold out of Humacyte (HUMA) in Q2 2026, closing a stake of 374 shares — an estimated $227 sold.

Wealth Preservation Advisors first reported a position in HUMA in Q1 2026 and held it in 1 quarter. The position peaked at $227 in Q1 2026. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Wealth Preservation Advisors reported no remaining Humacyte position as of Q2 2026 after selling out during the quarter.
  • Wealth Preservation Advisors sold 374 Humacyte shares in Q2 2026, an estimated $227.
  • Wealth Preservation Advisors first reported a position in Humacyte in Q1 2026 and held it in 1 quarter.
  • Wealth Preservation Advisors's Humacyte position peaked at $227 in Q1 2026.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Wealth Preservation Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.